---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-021361"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T18:01:57.475288+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Reviva prices $10M public offering of 20M shares and warrants at $0.50 per unit

## Summary
- Offering comprises 20M shares, 20M Series C warrants (5-year, $0.50 exercise), and 20M Series D warrants (12-month, $0.50 exercise).
- Gross proceeds of $10M; net proceeds expected ~$9.0M after fees.
- Net proceeds to fund R&D, working capital, and general corporate purposes.
- Closing expected June 27, 2025; 60-day lock-up on share issuance and one-year variable rate transaction restriction.
- A.G.P./Alliance Global Partners serving as sole placement agent with 7.0% cash fee.

## SEC filing metadata
- accession: 0001437749-25-021361
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774925021361/0001437749-25-021361-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774925021361/rvph20250626_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-021361
- JSON: https://secwatch.observer/filing/0001437749-25-021361.json
- Plain text: https://secwatch.observer/filing/0001437749-25-021361.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.